Clock gene and methods of use thereof
AssigneesThe Rockefeller University, Northwestern University
InventorsMichael W. Young, Brian Kloss, Justin Blau, Jeffrey Price, Joseph S. Takahashi, Phillip L. Lowrey
Life of this patent
Estimating the term…
Abstract
The present invention discloses the identity of the first enzyme that has been demonstrated to be involved in maintaining circadian rhythms. This enzyme, the Drosophila DOUBLETIME protein is also shown to be an ortholog of human casein kinase-1ε. In addition, a variant of this enzyme is shown to be cause of the hamster tau mutant phenotype. Thus the present invention also relates to variants of DOUBLETIME, and their nucleic acid and amino acid sequences. The present invention further provides methods of using these variants in drug assays and diagnostics.
Claims6
A DOUBLETIME protein comprising an amino acid sequence selected from the group consisting of:
- (a) SEQ ID NO:2;
- (b) SEQ ID NO:2 comprising a conservative substitution;
- (c) amino acid residues 1-292 of SEQ ID NO:2;
- and
- (d) amino acid residues 1-292 of SEQ ID NO:2 comprising a conservative substitution.
A DOUBLETIME protein comprising an amino acid sequence selected from the group consisting of:
- (a) a fragment of SEQ ID NO:2 exhibiting protein kinase activity;
- and
- (b) a fragment of SEQ ID NO:2 capable of binding a period (PER) protein.
A fusion protein comprising a polypeptide of interest fused to a polypeptide selected form the group consisting of:
- (a) an amino acid sequence comprising SEQ ID NO:2;
- (b) a fragment of the sequence of (a) exhibiting protein kinase activity;
- and
- (c) a proteolytic fragment of the sequence of (a) comprising six or more amino acid residues.
Dependencies are inferred from the claim text.